Terapêutica Sistémica no Melanoma Avançado Systemic Therapy in Advanced Melanoma

  • Cecília Moura Assistente Hospitalar Sénior - Serviço de Dermatologia - Instituto Português de Oncologia de Francisco Gentil Lisboa, Portugal




Download data is not yet available.


Seite S, Del Marmol V, Moyal D, Friedman AJ. Public primary and secondary skin cancer prevention,perceptions and knowledge: An international cross-sectional survey. J Eur Acad Dermatol Venereol. 2017;31:815–20. doi.org/10.1111/jdv.14104.

Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: Projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Investig Dermatol. 2016; 136:1161–71. doi.org/10.1016/j.jid.2016.01.035.

Mariotto AB, Yabroff KR, Shad Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011; 103:117–28. doi.org/10.1093/jnci/djq495.

Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane: Codon Publications; 2017. [accessed 2018 May 21]. doi.org/10.15586/codon.cutaneousmelanoma.2017.

Pires EM, Moura C. Systemic therapies for advanced melanoma: the immune checkpoint inhibitors. Rev Soc Port Dermatol Venereol. 2018: 76: doi.org/10.29021/spdv.76.3.970.

Boada A, Carrera C, Segura S, Collgros H, Pasquali P, Bodet D, et al. Cutaneous toxicities of new treatments for melanoma. Clin Transl Oncol. 2018 (in press). doi. org/10.1007/s12094-018-1891-7.

How to Cite
Moura, C. (2018). Terapêutica Sistémica no Melanoma Avançado Systemic Therapy in Advanced Melanoma. Journal of the Portuguese Society of Dermatology and Venereology, 76(3), 235-236. https://doi.org/10.29021/spdv.76.3.971